These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 28864379

  • 1. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice.
    Guo Y, Ding Q, Chen L, Ji C, Hao H, Wang J, Qi W, Xie X, Ma J, Li A, Jiang X, Li X, Jiang H.
    Am J Med Sci; 2017 Aug; 354(2):199-210. PubMed ID: 28864379
    [Abstract] [Full Text] [Related]

  • 2. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T, Yoshida Y, Kiso S, Kizu T, Furuta K, Ezaki H, Hamano M, Egawa M, Chatani N, Kamada Y, Imai Y, Higashiyama S, Iwamoto R, Mekada E, Takehara T.
    Biochem Biophys Res Commun; 2013 Jul 26; 437(2):185-91. PubMed ID: 23743191
    [Abstract] [Full Text] [Related]

  • 3. Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice.
    Huang G, Besner GE, Brigstock DR.
    Lab Invest; 2012 May 26; 92(5):703-12. PubMed ID: 22330337
    [Abstract] [Full Text] [Related]

  • 4. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
    Sakamoto K, Khai NC, Wang Y, Irie R, Takamatsu H, Matsufuji H, Kosai KI.
    Int J Mol Med; 2016 Dec 26; 38(6):1673-1682. PubMed ID: 27779646
    [Abstract] [Full Text] [Related]

  • 5. Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors.
    Zhang D, Zhang J, Jiang X, Li X, Wang Y, Ma J, Jiang H.
    J Gastroenterol Hepatol; 2014 Mar 26; 29(3):623-32. PubMed ID: 24303948
    [Abstract] [Full Text] [Related]

  • 6. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J, Lan T, Li C, Ji X, Zheng L, Gou H, Ou Y, Wu T, Qi C, Zhang Q, Li J, Gu Q, Wen D, Cao L, Qiao L, Ding Y, Wang L.
    J Hepatol; 2015 Dec 26; 63(6):1413-20. PubMed ID: 26264936
    [Abstract] [Full Text] [Related]

  • 7. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
    Yu J, Wu CW, Chu ES, Hui AY, Cheng AS, Go MY, Ching AK, Chui YL, Chan HL, Sung JJ.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):571-7. PubMed ID: 18503750
    [Abstract] [Full Text] [Related]

  • 8. Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.
    Lian H, Ma Y, Feng J, Dong W, Yang Q, Lu D, Zhang L.
    PLoS One; 2012 Aug 08; 7(9):e44946. PubMed ID: 22984591
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia.
    Means AL, Ray KC, Singh AB, Washington MK, Whitehead RH, Harris RC, Wright CV, Coffey RJ, Leach SD.
    Gastroenterology; 2003 Apr 08; 124(4):1020-36. PubMed ID: 12671899
    [Abstract] [Full Text] [Related]

  • 10. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
    Provenzano AP, Besner GE, James PF, Harding PA.
    Growth Factors; 2005 Mar 08; 23(1):19-31. PubMed ID: 16019424
    [Abstract] [Full Text] [Related]

  • 11. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.
    Kandhi R, Bobbala D, Yeganeh M, Mayhue M, Menendez A, Ilangumaran S.
    Cytokine; 2016 Jun 08; 82():58-69. PubMed ID: 26748724
    [Abstract] [Full Text] [Related]

  • 12. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
    Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H.
    Hepatology; 2000 Dec 08; 32(6):1248-54. PubMed ID: 11093731
    [Abstract] [Full Text] [Related]

  • 13. Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.
    Radulescu A, Zhang HY, Yu X, Olson JK, Darbyshire AK, Chen Y, Besner GE.
    J Pediatr Surg; 2010 Oct 08; 45(10):1933-9. PubMed ID: 20920709
    [Abstract] [Full Text] [Related]

  • 14. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
    David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Clézardin P, Peyruchaud O.
    PLoS One; 2014 Oct 08; 9(5):e97771. PubMed ID: 24828490
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.
    Li Z, Yan H, Yuan J, Cao L, Lin A, Dai H, Ni Z, Qian J, Fang W.
    Clin Exp Nephrol; 2018 Apr 08; 22(2):257-265. PubMed ID: 28710535
    [Abstract] [Full Text] [Related]

  • 16. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T, Tomita K, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Tominaga S, Hiroi S, Irie R, Okada Y, Kurihara C, Ebinuma H, Saito H, Hokari R, Sugiyama K, Kanai T, Miura S, Hibi T.
    Gastroenterology; 2012 Jan 08; 142(1):152-164.e10. PubMed ID: 21995947
    [Abstract] [Full Text] [Related]

  • 17. Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing.
    Radulescu A, Zhang HY, Chen CL, Chen Y, Zhou Y, Yu X, Otabor I, Olson JK, Besner GE.
    J Surg Res; 2011 Dec 08; 171(2):540-50. PubMed ID: 20850767
    [Abstract] [Full Text] [Related]

  • 18. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, Berasain C, Avila MA.
    Hepatology; 2008 Oct 08; 48(4):1251-61. PubMed ID: 18634036
    [Abstract] [Full Text] [Related]

  • 19. Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer.
    Tang XH, Deng S, Li M, Lu MS.
    Tumour Biol; 2016 Apr 08; 37(4):5521-8. PubMed ID: 26572150
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
    Hagiwara S, Otsuka T, Yamazaki Y, Kosone T, Sohara N, Ichikawa T, Sato K, Kakizaki S, Takagi H, Mori M.
    Liver Int; 2008 Jan 08; 28(1):126-31. PubMed ID: 17976157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.